The relationship between antibodies for the novel coronavirus (SARS-CoV-2) and immunity, vaccine efficacy, and spread of COVID-19 has received significant attention. Dr. Seheult is back to illustrate why T cells have received less attention than antibodies, but may be more important to long term immunity from COVID-19. Dr. Seheult also discusses how previous infections with common coronaviruses may provide some immunity to SARS-CoV-2, and the hypothesis that reducing the inoculum (initial dose) of SARS-CoV-2 might result in less symptom severity

Links / References:

5-Minute Sharable Video About At-Home Rapid Tests | https://www.medcram.com/courses/antig…

Johns Hopkins Tracker | https://coronavirus.jhu.edu/map.html

Worldometer | https://www.worldometers.info/coronav…

CNBC | https://www.cnbc.com/2020/08/07/coron…

Clinical Infectious Diseases | https://academic.oup.com/cid/advance-…

Cell | https://www.cell.com/cell/fulltext/S0…

Washington Post | https://www.washingtonpost.com/health… 

Nature | https://www.nature.com/articles/s4159…

Journal of General Internal Medicine (Reducing inoculum) | https://link.springer.com/article/10….

CDC | https://www.cdc.gov/mmwr/volumes/69/w…

NPR | https://www.npr.org/sections/health-s…

New York Times | https://www.nytimes.com/2018/09/21/we…

THE MEDCRAM WEBSITE: Visit for videos on over 60 medical topics and CME / CEs for medical professionals: https://www.medcram.com

SUBSCRIBE TO THE MEDCRAM YOUTUBE CHANNEL: https://www.youtube.com/user/MEDCRAMv…

 

News

COVID Vaccines Compared

There are three COVID-19 vaccines approved for use in the U.S. The Pfizer, Moderna, and Johnson & Johnson vaccines are all highly effective in protecting you from the virus that causes COVID-19. The Pfizer [...]